Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease-Reference-Cited by-同舟云学术

Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease

Published:2019-07 Issue: Volume:127 Page:163-177
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Spencer Brian^ORCID,Trinh Ivy,Rockenstein Edward,Mante Michael,Florio Jazmin,Adame Anthony,El-Agnaf Omar M.A.,Kim Changyoun,Masliah Eliezer,Rissman Robert A.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Neurology

Reference111 articles.

1. Astrocyte-endothelial interactions at the blood-brain barrier;Abbott;Nat. Rev. Neurosci.,2006

2. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system;Abeliovich;Neuron,2000

3. Alpha-synucleinopathies;Alafuzoff;Handb. Clin. Neurol.,2017

4. Selective alpha-synuclein knockdown in monoamine neurons by intranasal oligonucleotide delivery: potential therapy for Parkinson's disease;Alarcon-Aris;Mol. Ther.,2018

5. Gene therapy strategies for Alzheimer's disease: an overview;Alves;Hum. Gene Ther.,2016

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Therapeutic Horizons: SNCA Targeting in Parkinson’s Disease;Biomolecules;2024-08-06

2. RNA therapies for CNS diseases;Advanced Drug Delivery Reviews;2024-05

3. Corrigendum to “ Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy Body Disease” [Neurobiology of Disease127 (2019) 163–177];Neurobiology of Disease;2024-02

4. Advances in carrier-delivered small interfering RNA based therapeutics for treatment of neurodegenerative diseases;Biomaterials Science;2024

5. Novel systemic delivery of a peptide-conjugated antisense oligonucleotide to reduce α-synuclein in a mouse model of Alzheimer's disease;Neurobiology of Disease;2023-10